Expression of placenta-specific 1 and its potential for eliciting anti-tumor helper T-cell responses in head and neck squamous cell carcinoma

Long-term surviving cancer patients as a source of therapeutic TCR

(2020) Else Marit Inderberg et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Phosphorylated vimentin as an immunotherapeutic target against metastatic colorectal cancer

(2020) Mizuho Ohara et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Intratumoral CD4+ T Cells Mediate Anti-tumor Cytotoxicity in Human Bladder Cancer

(2020) David Y. Oh et al.   CELL

The route of administration dictates the immunogenicity of peptide-based cancer vaccines in mice

(2019) Hussein Sultan et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

High Beclin-1 and ARID1A expression corelates with poor survival and high recurrence in intrahepatic cholangiocarcinoma: a histopathological retrospective study

(2019) Chao Bi et al.   BMC CANCER

PLAC1: biology and potential application in cancer immunotherapy

(2019) Jafar Mahmoudian et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

PD-L1-specific helper T-cells exhibit effective antitumor responses: new strategy of cancer immunotherapy targeting PD-L1 in head and neck squamous cell carcinoma

(2019) Yui Hirata-Nozaki et al.   Journal of Translational Medicine

Single-cell transcriptomics reveals expansion of cytotoxic CD4 T cells in supercentenarians

(2019) Kosuke Hashimoto et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Cancer/testis antigen-Plac1 promotes invasion and metastasis of breast cancer through Furin/NICD/PTEN signaling pathway

(2018) Yongfei Li et al.   Molecular Oncology

PLAC1 as a serum biomarker for breast cancer

(2018) Hongyan Yuan et al.   PLoS One

PLAC1-specific TCR-engineered T cells mediate antigen-specific antitumor effects in breast cancer

(2018) Qiongshu Li et al.   Oncology Letters

Plac1 Is a Key Regulator of the Inflammatory Response and Immune Tolerance In Mammary Tumorigenesis

(2018) Hongyan Yuan et al.   Scientific Reports

Targeting phosphorylated p53 to elicit tumor-reactive T helper responses against head and neck squamous cell carcinoma

(2018) Kenzo Ohara et al.   OncoImmunology

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

(2018) Freddie Bray et al.   CA-A CANCER JOURNAL FOR CLINICIANS

The Immune Epitope Database (IEDB): 2018 update

(2018) Randi Vita et al.   NUCLEIC ACIDS RESEARCH

Placenta-Specific Protein 1 Expression in Human Papillomavirus 16/18–Positive Cervical Cancers Is Associated With Tumor Histology

(2017) Eric J. Devor et al.   INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER

p53 mutation status is a primary determinant of placenta-specific protein 1 expression in serous ovarian cancers

(2017) Eric J. Devor et al.   INTERNATIONAL JOURNAL OF ONCOLOGY

Treatment of Patients With Metastatic Cancer Using a Major Histocompatibility Complex Class II–Restricted T-Cell Receptor Targeting the Cancer Germline Antigen MAGE-A3

(2017) Yong-Chen Lu et al.   JOURNAL OF CLINICAL ONCOLOGY

Placenta-specific protein 1 promotes cell proliferation and invasion in non-small cell lung cancer

(2017) Li Yang et al.   ONCOLOGY REPORTS

Expression and clinical significance of placenta-specific 1 in pancreatic ductal adenocarcinoma

(2017) Yin Yin et al.   TUMOR BIOLOGY

The present status and future prospects of peptide-based cancer vaccines

(2016) Masatoshi Hirayama et al.   INTERNATIONAL IMMUNOLOGY

Mutations Associated with Acquired Resistance to PD-1 Blockade in Melanoma

(2016) Jesse M. Zaretsky et al.   NEW ENGLAND JOURNAL OF MEDICINE

Oncogenic function of Plac1 on the proliferation and metastasis in hepatocellular carcinoma cells

(2016) Yuan Wu et al.   ONCOLOGY REPORTS

Optimization of Peptide Vaccines to Induce Robust Antitumor CD4 T-cell Responses

(2016) Takumi Kumai et al.   Cancer Immunology Research

Epigenetic modification augments the immunogenicity of human leukocyte antigen G serving as a tumor antigen for T cell-based immunotherapy

(2016) Kei Ishibashi et al.   OncoImmunology

CCL17 and CCL22/CCR4 signaling is a strong candidate for novel targeted therapy against nasal natural killer/T-cell lymphoma

(2015) Takumi Kumai et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

New tumour antigen PLAC1/CP1, a potentially useful prognostic marker and immunotherapy target for gastric adenocarcinoma

(2015) Fangfang Liu et al.   JOURNAL OF CLINICAL PATHOLOGY

High placenta-specific 1/low prostate-specific antigen expression pattern in high-grade prostate adenocarcinoma

(2014) Roya Ghods et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Cancer Immunotherapy Based on Mutation-Specific CD4+ T Cells in a Patient with Epithelial Cancer

(2014) E. Tran et al.   SCIENCE

Identification of two new HLA-A*0201-restricted cytotoxic T lymphocyte epitopes from colorectal carcinoma-associated antigen PLAC1/CP1

(2013) Fangfang Liu et al.   JOURNAL OF GASTROENTEROLOGY

Molecular Subtypes in Head and Neck Cancer Exhibit Distinct Patterns of Chromosomal Gain and Loss of Canonical Cancer Genes

(2013) Vonn Walter et al.   PLoS One

HLA DR15 Antigen Status Does Not Impact Graft-versus-Host Disease or Survival in HLA-Matched Sibling Transplantation for Hematologic Malignancies

(2012) Minoo Battiwalla et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

BiVax: a peptide/poly-IC subunit vaccine that mimics an acute infection elicits vast and effective anti-tumor CD8 T-cell responses

(2012) Hyun-Il Cho et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Identification of a novel HLA-A2-restricted cytotoxic T lymphocyte epitope from cancer-testis antigen PLAC1 in breast cancer

(2011) Wei Liu et al.   AMINO ACIDS

Cytotoxic CD4 T Cells in Antiviral Immunity

(2011) Nikki B. Marshall et al.   JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY

Interferon   limits the effectiveness of melanoma peptide vaccines

(2010) H.-I. Cho et al.   BLOOD

A new era in anticancer peptide vaccines

(2010) Sonia A. Perez et al.   CANCER

Tumor-reactive CD4+T cells develop cytotoxic activity and eradicate large established melanoma after transfer into lymphopenic hosts

(2010) Sergio A. Quezada et al.   JOURNAL OF EXPERIMENTAL MEDICINE

PLAC1 (Placenta-specific 1): a novel, X-linked gene with roles in reproductive and cancer biology

(2010) Michael Fant et al.   PRENATAL DIAGNOSIS

Analysis of chemokine and chemokine receptor expression in squamous cell carcinoma of the head and neck (SCCHN) cell lines

(2010) Hendrik A. Wolff et al.   RADIATION AND ENVIRONMENTAL BIOPHYSICS

The Specific Immune Response to Tumor Antigen CP1 and Its Correlation With Improved Survival in Colon Cancer Patients

(2008) Fang–Fang Liu et al.   GASTROENTEROLOGY

Plac1 is a tumor-specific antigen capable of eliciting spontaneous antibody responses in human cancer patients

(2008) Xue-Yuan Dong et al.   INTERNATIONAL JOURNAL OF CANCER

Head and neck cancer

(2008) Athanassios Argiris et al.   LANCET

Treatment of Metastatic Melanoma with Autologous CD4+ T Cells against NY-ESO-1

(2008) Naomi N. Hunder et al.   NEW ENGLAND JOURNAL OF MEDICINE